Clinical Significance of Serum Mesothelin in Patients with Mesothelioma and Lung Cancer
Source: Clinical Cancer Research
High levels of serum-soluble mesothelin family proteins (SMRP) have been associated as a possible biomarker for malignant mesothelioma and lung cancer. A study was commissioned to look at SMRP levels in the largest population of thoracic cancers ever assembled. The study attempted to quantify if SMRP levels were of prognostic or diagnostic value for either malignant mesothelioma or lung cancer. Results indicated great promise for SMRP levels as a biomarker for mesothelioma and indicated possible promise for its diagnostic use with lung cancers.
High levels of serum-soluble mesothelin family proteins (SMRP) have been associated as a possible biomarker for malignant mesothelioma and lung cancer. A study was commissioned to look at SMRP levels in the largest population of thoracic cancers ever assembled. The study attempted to quantify if SMRP levels were of prognostic or diagnostic value for either malignant mesothelioma or lung cancer. Results indicated great promise for SMRP levels as a biomarker for mesothelioma and indicated possible promise for its diagnostic use with lung cancers.
Labels: mesothelioma
posted by Belluck & Fox at
4:10 PM
© Belluck & Fox, L.L.P. All rights reserved.
